All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
This product is the plasmid containing an encoded anti-FKBP5 DMAb sequence. The plasmid can drive transcription and in vivo translation of the desired antibody.
Sub CAT. | DMAb Clone | DMAb Host | Target Species | DMAb Isotype | DMAb Immunogen | |
DMAb-1010-CQ | CBXF-1228 | Rabbit | IgG | |||
DMAb-1011-CQ | Hi51B | Mouse | IgG | Synthetic peptide corresponding to the residues of human FKBP51 | ||
DMAb-1012-CQ | CBXF-0716 | Mouse | IgG2b, κ | |||
DMAb-1013-CQ | CBXF-1973 | Mouse | IgG1 | Mouse FKBP51 aa. 4-199 | ||
DMAb-1014-CQ | CBXF-3534 | Mouse | IgG1 | |||
DMAb-1015-CQ | CBXF-2240 | Rabbit | IgG | Protein corresponding to Human FKBP5 (aa 298-447) | ||
DMAb-1016-CQ | CBXF-2241 | Rabbit | IgG | Peptide corresponding to Human FKBP5 (aa 298-447) | ||
DMAb-1017-CQ | CBXF-2064 | Rabbit | IgG | |||
DMAb-1018-CQ | CBXF-2645 | Rat | IgG2b | E. coli-derived recombinant human FKBP51, Met1-Val457, Accession # Q13451 | ||
DMAb-1019-CQ | CBXF-0715 | Mouse | IgG1, κ | FKBP5 (AAH42605, 1 a.a.-457 a.a) full-length recombinant protein with GST tag | ||
DMAb-1020-CQ | CBXF-3053 | Mouse | IgG2b, κ | Full length recombinant corresponding to aa1-457 from human FKBP5 (AAH42605) with GST tag | ||
DMAb-1021-CQ | CBXF-3054 | Mouse | IgG | FKBP5 (AAH42605, 1aa-457aa) full-length recombinant protein with GST tag | ||
DMAb-1022-CQ | CBXF-3347 | Mouse | IgG | Full length his-tagged human recombinant FKBP51 |
There are currently no customer reviews or questions for Anti-FKBP5 DNA-encoded mAb (DMAb), pVAX1 (DMAb-1010-CQ). Click the button below to contact us or submit your feedback about this product.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION